• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

Investigating Cardiac Dysfunctions Among Chronic Liver Disease Patients

    Shobha Kumar Prasad, Anil Kumar Mehta

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 1386-1390

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background- Chronic liver disease (CLD) causes pathological alterations in the
myocardium in addition to the typical hemodynamic abnormalities. Since the reduced
systemic vascular resistance usually compensates for overt heart failure, cardiac
pathology is frequently disregarded.
Methods- The current investigation was carried out at the Darbhanga Medical College
& Hospital, Darbhanga as an observational study. A total of 75 patients with chronic
liver disease were included in the study. After being interviewed, their demographic
data, symptoms, and presentation were collected. Then, all of the patients underwent
thorough physical examinations, 2D ECHO and ECG cardiological assessments, and
blood investigations.
Results: Patients without cardiac dysfunction had a mean age of 40.3 years, whereas
those with cardiac dysfunction had a mean age of 46.25 years. Cardiac dysfunctions in
CLD patients most frequently affected individuals between the ages of 51 and 60, and
96% of cases included men and 4% involved women. In 28% of individuals, QTc
prolongation was identified. Diastolic dysfunctions were common in 24% of CLD
patients, while systolic dysfunctions were common in 20% of them.
Conclusion- In order to consider the presence of CV dysfunction and cirrhotic
cardiomyopathy in CLD patients and estimate the risk of unfavourable cardiac events,
a high level of awareness is required. To enhance these individuals' prognoses, more
research is required on particular therapy approaches
Keywords:
  • PDF (83 K)
  • XML
(2022). Investigating Cardiac Dysfunctions Among Chronic Liver Disease Patients. European Journal of Molecular & Clinical Medicine, 9(4), 1386-1390.
Shobha Kumar Prasad, Anil Kumar Mehta. "Investigating Cardiac Dysfunctions Among Chronic Liver Disease Patients". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 1386-1390.
(2022). 'Investigating Cardiac Dysfunctions Among Chronic Liver Disease Patients', European Journal of Molecular & Clinical Medicine, 9(4), pp. 1386-1390.
Investigating Cardiac Dysfunctions Among Chronic Liver Disease Patients. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 1386-1390.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 47
  • PDF Download: 71
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus